On the stock market since 2021, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
No real growth (-1% a year). Red columns mark years that ended in a loss.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $53.4M a year. A small number, but proof the product has real buyers.
It pays out $0.0050 per share each year — regular cash for whoever holds the stock.
A loss of $44.7M against $53.4M in annual sales.
On our five-subject report card, ACUSX sits in the middle of the class: some subjects shine, others don’t. The grade moves as the numbers move.
The takeaway: ACUSX is a high-risk stock — not yet profitable, and its future rides on its product catching on.